Find results that contain all of your keywords. Content filter is on. Search will return best illustrations, stock vectors and clipart.
Make it so!
You have chosen to exclude "" from your results.

Choose orientation:
Related commercial searches:

pralsetinib

cancer

drug

molecule

3d

rendering

anaplastic

 lymphoma kinase alk tyrosine domain protein shown complex inhibitor crizotinib pembrolizumab monoclonal antibody immune checkpoint targetting pd used treatment number
of 6 ← →
Order by: relevancy of keywords | publishing date | most downloaded

Nsclc Cartoons, Illustrations & Vector Stock Images

- 148 images
Pralsetinib cancer drug molecule. 3D rendering.
Anaplastic lymphoma kinase (ALK, tyrosine kinase domain) protein. Shown in complex with the inhibitor crizotinib. 3D rendering
Anaplastic lymphoma kinase (ALK, tyrosine kinase domain) protein. Shown in complex with the inhibitor crizotinib. 3D rendering
Pembrolizumab monoclonal antibody drug protein. Immune checkpoint inhibitor targetting PD-1, used in the treatment of a number of.
Pembrolizumab monoclonal antibody drug protein. Immune checkpoint inhibitor targetting PD-1, used in the treatment of a number of.
Pembrolizumab monoclonal antibody drug protein. Immune checkpoint inhibitor targetting PD-1, used in the treatment of a number of.
Pembrolizumab monoclonal antibody drug protein. Immune checkpoint inhibitor targetting PD-1, used in the treatment of a number of.
Pembrolizumab monoclonal antibody drug protein. Immune checkpoint inhibitor targetting PD-1, used in the treatment of a number of.
Pembrolizumab monoclonal antibody drug protein. Immune checkpoint inhibitor targetting PD-1, used in the treatment of a number of.
Pembrolizumab monoclonal antibody drug protein. Immune checkpoint inhibitor targetting PD-1, used in the treatment of a number of.
Pembrolizumab monoclonal antibody drug. Targets Programmed cell Death 1 (PD-1) and is used in the treatment of cancer (immune
Monoclonal antibody treatment in lung cancer (LC) - closeup view 3d illustration
Anaplastic lymphoma kinase (ALK, tyrosine kinase domain) protein. Shown in complex with the inhibitor crizotinib. 3D rendering
Crizotinib molecular structure isolated on white
Crizotinib molecular structure isolated on white
Crizotinib molecular structure isolated on white
Pembrolizumab monoclonal antibody drug protein. Immune checkpoint inhibitor targetting PD-1, used in the treatment of a number of.
Crizotinib anti-cancer drug molecule. Inhibitor of ALK and ROS1 proteins.
CAR T cell therapy in lung cancer (LC) - closeup view 3d illustration
CAR T cell therapy in lung cancer (LC) - closeup view 3d illustration
Crizotinib molecular structure isolated on white
Crizotinib molecular structure isolated on white
Crizotinib molecular structure isolated on white
Crizotinib anti-cancer drug molecule. Inhibitor of ALK and ROS1 proteins
Crizotinib anti-cancer drug molecule. Inhibitor of ALK and ROS1 proteins
Crizotinib anti-cancer drug molecule. Inhibitor of ALK and ROS1 proteins
Crizotinib anti-cancer drug molecule. Inhibitor of ALK and ROS1 proteins
Next Page
←↑↓→
See more images